Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pituitary Neoplasms × pasireotide × Clear all

Phase

Status

Sponsor Class

INDUSTRY 6 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 3 Neuroendocrine Tumors 3 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Liver Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Hepatocellular 2 Carcinoid Tumor 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Sarcoma, Synovial 1 Prolactinoma 1 Prolactin-Producing Pituitary Tumor 1 Primary Inoperable Thymoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pituitary Neoplasms 1 Peritoneal Neoplasms 1 Pancreatic Fistula 1 Neoplasms 1 Nelson Syndrome 1 Myelodysplastic Syndromes 1 Meningioma 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Insulinoma 1 Hypoglycemia 1 Hyperinsulinism 1 Hematologic Neoplasms 1

Interventions

Surgical Procedures, Operative 4 Cabergoline 4 Temozolomide 3 Propofol 3 Hydrocortisone 3 Dexmedetomidine 3 lanreotide 2 Sevoflurane 2 Saline Solution 2 Rosiglitazone 2 Radiotherapy 2 Radiosurgery 2 Proton Therapy 2 Human Growth Hormone 2 Desflurane 2 Aminolevulinic Acid 2 pasireotide 1 parecoxib 1 lutetium Lu 177 dotatate 1 loxoprofen 1 Yoga 1 Visual Field Tests 1 Visual Acuity 1 Trimethoprim 1 Transcranial Magnetic Stimulation 1 Tranexamic Acid 1 Tramadol 1 Surveys and Questionnaires 1 Supine Position 1 Sulfamethoxazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00929669 2017-11-28

LAR

University of Pennsylvania

Phase 2 Terminated

2 enrolled 3 charts

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡